West Pharmaceutical Services, Inc. (WST) has a consensus analyst rating of Buy, based on 14 analysts covering the stock. Of those, 10 recommend buying, 3 recommend holding, and 1 recommend selling.
The analyst consensus price target for WST is $303.33, representing a +13.2% upside from the current price of $267.93. Price targets range from a low of $265.00 to a high of $340.00.
